ARS Pharmaceuticals, Inc. (SPRY) Current Liabilities

Annual Current Liabilities:

$23.44M+$21.05M(+880.34%)
December 31, 2024

Summary

  • As of today, SPRY annual current liabilities is $23.44 million, with the most recent change of +$21.05 million (+880.34%) on December 31, 2024.
  • During the last 3 years, SPRY annual current liabilities has risen by +$15.25 million (+186.31%).
  • SPRY annual current liabilities is now at all-time high.

Performance

SPRY Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Quarterly Current Liabilities:

$50.88M+$5.28M(+11.57%)
September 30, 2025

Summary

  • As of today, SPRY quarterly current liabilities is $50.88 million, with the most recent change of +$5.28 million (+11.57%) on September 30, 2025.
  • Over the past year, SPRY quarterly current liabilities has increased by +$34.25 million (+206.06%).
  • SPRY quarterly current liabilities is now at all-time high.

Performance

SPRY Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

SPRY Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+880.3%+206.1%
3Y3 Years+186.3%+1175.1%
5Y5 Years+30.8%+429.9%

SPRY Current Liabilities Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+880.3%at high+2027.8%
5Y5-Yearat high+880.3%at high+2027.8%
All-TimeAll-Timeat high+880.3%at high+2027.8%

SPRY Current Liabilities History

DateAnnualQuarterly
Sep 2025
-
$50.88M(+11.6%)
Jun 2025
-
$45.60M(+65.1%)
Mar 2025
-
$27.62M(+17.8%)
Dec 2024
$23.44M(+880.3%)
$23.44M(+41.0%)
Sep 2024
-
$16.62M(+147.2%)
Jun 2024
-
$6.72M(+81.0%)
Mar 2024
-
$3.71M(+55.4%)
Dec 2023
$2.39M(-56.1%)
$2.39M(-78.6%)
Sep 2023
-
$11.18M(+11.2%)
Jun 2023
-
$10.05M(+2.2%)
Mar 2023
-
$9.84M
DateAnnualQuarterly
Dec 2022
$5.44M(-33.5%)
-
Sep 2022
-
$3.99M(-64.2%)
Jun 2022
-
$11.14M(-24.8%)
Mar 2022
-
$14.81M(-0.6%)
Dec 2021
$8.19M(-14.7%)
-
Dec 2021
-
$14.89M(-3.0%)
Sep 2021
-
$15.35M(-1.3%)
Jun 2021
-
$15.55M(+34.1%)
Mar 2021
-
$11.60M(+20.8%)
Dec 2020
$9.60M(-46.4%)
$9.60M(-46.4%)
Dec 2019
$17.93M(+248.5%)
$17.93M
Dec 2018
$5.14M
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual current liabilities?
  • What is the all-time high annual current liabilities for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual current liabilities year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly current liabilities?
  • What is the all-time high quarterly current liabilities for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?

What is ARS Pharmaceuticals, Inc. annual current liabilities?

The current annual current liabilities of SPRY is $23.44M

What is the all-time high annual current liabilities for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual current liabilities is $23.44M

What is ARS Pharmaceuticals, Inc. annual current liabilities year-on-year change?

Over the past year, SPRY annual current liabilities has changed by +$21.05M (+880.34%)

What is ARS Pharmaceuticals, Inc. quarterly current liabilities?

The current quarterly current liabilities of SPRY is $50.88M

What is the all-time high quarterly current liabilities for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly current liabilities is $50.88M

What is ARS Pharmaceuticals, Inc. quarterly current liabilities year-on-year change?

Over the past year, SPRY quarterly current liabilities has changed by +$34.25M (+206.06%)
On this page